March 2012
Volume 53, Issue 14
ARVO Annual Meeting Abstract  |   March 2012
Rational For ILM Removal In Diabetic Retinopathy
Author Affiliations & Notes
  • Constantin J. Pournaras
    Vitreo-retinal Unit, Ophthalmology,
    Geneva University Hospitals, Geneva, Switzerland
  • Marie-Luce Bochaton-Piallat
    Department of Pathology and Immunology,
    Geneva University Hospitals, Geneva, Switzerland
  • Nicole Gilodi
    Department of Ophthalmology, Geneva University Hospitals, Geneva, Switzerland
  • Efstratios Mendrinos
    Vitreo-retinal Unit, Ophthalmology,
    Geneva University Hospitals, Geneva, Switzerland
  • Footnotes
    Commercial Relationships  Constantin J. Pournaras, None; Marie-Luce Bochaton-Piallat, None; Nicole Gilodi, None; Efstratios Mendrinos, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 363. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Constantin J. Pournaras, Marie-Luce Bochaton-Piallat, Nicole Gilodi, Efstratios Mendrinos; Rational For ILM Removal In Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2012;53(14):363.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Myofibroblasts play a major role in the production of retractile phenomena causing contraction or shrinkage of the epiretinal membranes (ERM) in proliferative vitreoretinopathy, diabetic retinopathy or idiopathic macular epiretinal membranes. To evaluate the expression of myofibroblasts on epiretinal macular tissue, in eyes with diabetic retinopathy undergoingvitrectomy.

Methods: : Samples of ERMs and/or ILMs following macular surgery in eyes with diabetic maculopathy or other diabetic-related complications were collected in 13 eyes. Samples included ILMs only in 7 eyes, ERMs only in 2 eyes and ERM with ILM in 4 eyes. Double immunofluorescence staining with antibodies recognizing a-SMA and ED-A FN or vimentine in myofibroblasts, followed by confocal microscopy analysis as well as electronic microscopy were performed in all samples.

Results: : a-SMA in association to either ED-A FN or vimentine were detected in all ERM samples with or without ILM. In addition, ED-A FN or vimentine was expressed in close relation with a-SMA-positive myofibroblasts in 2 out of 7 ILM samples.

Conclusions: : Scanning electron microscopy indicated that myofibroblats cellular migration is always expressed in epiretinal macular membrane. Most (5/7) of the ILM samples were negative for myofibroblasts, whereas 2 stained positive. These results suggest that in some cases ILM may contain myofibroblasts with no macroscopic evidence of ERM. If during surgery, the ILM is colored inhomogeneously, this suggests the presence of cells and should be peeled. If the ILM is colored homogeneously, peeling is not considered necessary.

Keywords: diabetic retinopathy 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.